Back to BAKER BROS. ADVISORS LP BAKER BROS. ADVISORS LP

RYTMRYTM
Showing 8 of 30 quarters

Position history for BAKER BROS. ADVISORS LPBAKER BROS. ADVISORS LP's holdings in RHYTHM PHARMACEUTICALS INC

BAKER BROS. ADVISORS LP holds 5.6M shares of RYTM (RHYTHM PHARMACEUTICALS INC), worth $622.3M as of 2026-Q2. RYTM represents 3.1% of BAKER BROS. ADVISORS LP's portfolio.

Current Value

$622.3M

Current Shares

5.6M

Total Value Change

+$287.1M

Total Shares Change

-793,883

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Unchanged
5.6M
0.0%
$622.3M3.1%$111.03
0
2026-Q1
Unchanged
5.6M
0.0%
$487.4M2.8%$89.56
0
2025-Q4
Unchanged
5.6M
0.0%
$599.9M3.5%$106.76
0
2025-Q3
Unchanged
5.6M
0.0%
$566M4.1%$100.64
0
2025-Q2
Unchanged
5.6M
0.0%
$354.1M3.4%$62.73
0
2025-Q1
Decreased
5.6M
-7.9%
$296.9M3.3%$54.80
0
2024-Q4
Decreased
6.1M
-4.9%
$340.6M3.6%$56.34
0
2024-Q3
Increased
6.4M
0.0%
$335.2M3.5%$51.35
57

Other major holders of RYTM: RA CAPITAL MANAGEMENT, L.P., BlackRock, Inc., VANGUARD GROUP INC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used